Home

Persécuter Préface secouer cas de dopage tennis 2018 dessert le goudron charité

CAS extends Errani's doping ban to 10 months
CAS extends Errani's doping ban to 10 months

Nike stand by Maria Sharapova despite Russian tennis star's two-year doping  ban - Mirror Online
Nike stand by Maria Sharapova despite Russian tennis star's two-year doping ban - Mirror Online

THE COURT OF ARBITRATION FOR SPORT (CAS) INCREASES THE SUSPENSION OF  ITALIAN TENNIS PLAYER SARA ERRANI, FROM 2 To 10 MONTH. – ANTI-DOPING WORLD
THE COURT OF ARBITRATION FOR SPORT (CAS) INCREASES THE SUSPENSION OF ITALIAN TENNIS PLAYER SARA ERRANI, FROM 2 To 10 MONTH. – ANTI-DOPING WORLD

Errani 'disgusted' by extended doping suspension | Reuters
Errani 'disgusted' by extended doping suspension | Reuters

Sharapova appeals to CAS in doping case; ruling by July 18 | Fox News
Sharapova appeals to CAS in doping case; ruling by July 18 | Fox News

Belarussian Tennis Federation appeal to CAS over ITF ban
Belarussian Tennis Federation appeal to CAS over ITF ban

Maria Sharapova doping: Sponsors Nike and Head stand by disgraced tennis  star as two-year ban is labelled as 'flawed' | The Independent | The  Independent
Maria Sharapova doping: Sponsors Nike and Head stand by disgraced tennis star as two-year ban is labelled as 'flawed' | The Independent | The Independent

Andy Murray: Fatherhood played key role in Wimbledon title | CNN
Andy Murray: Fatherhood played key role in Wimbledon title | CNN

Maria Sharapova's doping ban cut from two years to 15 months - Los Angeles  Times
Maria Sharapova's doping ban cut from two years to 15 months - Los Angeles Times

A Doping Ban And Frosty Friendships Failed To Stop Maria Sharapova Becoming  A Tennis Icon - UBITENNIS
A Doping Ban And Frosty Friendships Failed To Stop Maria Sharapova Becoming A Tennis Icon - UBITENNIS

Yastremska's appeal against provisional doping ban rejected by CAS again
Yastremska's appeal against provisional doping ban rejected by CAS again

Dopage: le cas Sharapova, une façon pour le tennis de s'acheter une  crédibilité? - L'Express
Dopage: le cas Sharapova, une façon pour le tennis de s'acheter une crédibilité? - L'Express

Sharapova to find out first week of October whether two-year doping ban  reduced
Sharapova to find out first week of October whether two-year doping ban reduced

Maria Sharapova: Key facts of the ITF doping decision and her chances on  appeal - LawInSport
Maria Sharapova: Key facts of the ITF doping decision and her chances on appeal - LawInSport

First doping case of 2018 Winter Olympics sees Japanese athlete sent home |  Winter Olympics 2018 | The Guardian
First doping case of 2018 Winter Olympics sees Japanese athlete sent home | Winter Olympics 2018 | The Guardian

Olympic Champion Vesnina says Maria Sharapova's absence on court is  'negative for tennis' - Sport - TASS
Olympic Champion Vesnina says Maria Sharapova's absence on court is 'negative for tennis' - Sport - TASS

CAS rejects Dayana Yastremska's appeal against doping ban again ·  tennisnet.com
CAS rejects Dayana Yastremska's appeal against doping ban again · tennisnet.com

Sara Errani doping suspension increased to 10 months by CAS - Eurosport
Sara Errani doping suspension increased to 10 months by CAS - Eurosport

Simona Halep vows to 'fight for the truth' after positive doping test |  Simona Halep | The Guardian
Simona Halep vows to 'fight for the truth' after positive doping test | Simona Halep | The Guardian

Viktor Troicki has doping ban reduced from 18 months to 12 by CAS | Tennis  News | Sky Sports
Viktor Troicki has doping ban reduced from 18 months to 12 by CAS | Tennis News | Sky Sports

Now I must defend myself' - Yastremska sees doping ban appeal rejected
Now I must defend myself' - Yastremska sees doping ban appeal rejected

CAS increases Sara Errani's doping suspension to 10 months - Red Deer  Advocate
CAS increases Sara Errani's doping suspension to 10 months - Red Deer Advocate

The drug Simona Halep tested positive for is part of a new class of blood  agents : NPR
The drug Simona Halep tested positive for is part of a new class of blood agents : NPR